ESC Professional Premium Access

Management of doxorubicin-induced cardiomyopathy as the adverse event of chemotherapy in acute critical decompensated heart failure: a case report.

Congress Presentation

About the speaker

Doctor Tomoyuki Nagai

Kyoto Prefectural University of Medicine, Kyoto (Japan)
1 presentation
0 follower

4 more presentations in this session

Cardio-oncology – Cancer treatment and cardiovascular toxicity - Get ready for the session.


Cardiotoxicity evaluation in a patient with recidivant breast cancer and rheumatic heart disease.

Speaker: Doctor A. Issa (Rio de Janeiro, BR)


CAR-T cell induced takotsubo syndrome: a case report.

Speaker: Associate Professor F. Guerra (Ancona, IT)


Multimodality imaging approach in a vascular toxicity case caused by cabozantinib.

Speaker: Doctor G. Benetos (Athens, GR)


Access the full session

Cardio-oncology – Cancer treatment and cardiovascular toxicity

Speakers: Doctor T. Nagai, Doctor A. Issa, Associate Professor F. Guerra, Doctor G. Benetos

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb